TrialBritish journal of cancer2013

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial.

J E Bauman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.